Authors
Latest:
Manufacturer Considerations for Designing a Distribution Strategy for Specialty ProductsThe rising cost of specialty drugs continues to put pressure on all stakeholders. Specialty pharmacists can fill an existing gap in compliance and cost control.
Latest:
Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung CancerA national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.
Latest:
Artificial Intelligence Applications in Education and Pharmacy PracticeBy interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Latest:
Implications of STeP for Improved Diabetes Control: A Payer PerspectiveImplementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.
Latest:
US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic ConstipationThe perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.
Latest:
Student Pharmacist Leaders Discuss the Future of PharmacyStudent pharmacist leaders were also asked about the importance of a pharmacist education in obtaining advanced pharmacist roles in their careers.
Latest:
Ensuring Access to Vaccinations Among Older Adults and Underserved PopulationsA broader understanding of vaccine hesitancy and barriers has helped to enhance acceptance of vaccination services through educational outreach.
Latest:
Medicare Part D Plans Burdened by Hospice Payment ReformRecent guidance and proposed rules for the Medicare hospice program will have a profound impact on plans providing Medicare Part D services.
Latest:
Treatment of Acute Venous Thromboembolism in Obese PatientsIn the United States, as many as 900,000 individuals are affected by venous thromboembolism each year.
Latest:
Electronic Prior Authorization: The First Step in Patient AdherenceA streamlined prior authorization process can increase administrative efficiency and improve health information security.
Latest:
5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk FactorsPalonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.
Latest:
Success Stories of Interprofessional EducationLike many things at a large state school, in order to find opportunities, you must seek them yourself.
Latest:
Controlling Diabetes: Teaching Patients to Take ChargeThe American Diabetes Association recommends that health care providers incorporate an estimated average glucose measurement when counseling patients with diabetes.
Latest:
Pharmacy and Telehealth: An Interprofessional Model at a Student-led Free ClinicUnique model demonstrates how clinical pharmacy services could be integrated into an interprofessional telehealth clinic.
Latest:
Pifeltro and Delstrigo: New Options for HIV-1On August 30, 2018, the FDA approved Merck’s doravirine (Pifeltro) a non-nucleoside reverse transcriptase inhibitor and doravirine/lamivudine/tenofovir (Delstrigo) a once-daily single tablet regimen for the treatment of HIV-1 infection in appropriate patients.
Latest:
Clinical Insights: Use of Combination Therapy for Advanced Clear-Cell Renal Cell CarcinomaApproximately 73,000 NEW cases of renal cell carcinoma (RCC) are expected to be diagnosed in 2019 in the United States, with up to 70% of these cases anticipated to be clear-cell subtype.
Latest:
Affordable Care Act Regards Pharmacists as Health Care Providers, Not Just Prescription DispensersLaw sets precedent for pharmacists to provide cognitive care-and charge for it
Latest:
Synchronization of Treatment With Erythropoiesis-Stimulating Agents and ChemotherapyIn outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.
Latest:
Incentive Formularies: Spending and Utilization for 3 Common Drug ClassesIncentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.
Latest:
All My Pharmacy Students Learn to CodeWhy I included a computer coding aspect into my APPE rotation
Latest:
4 Pharmacy Accounting, Tax TipsTo avoid the tax pitfalls of procrastination, here are 4 accounting and tax tips to implement!
Latest:
You Are Probably Getting Too Much SodiumMany of us take in too much sodium, which can put us at an increased risk for health problems.
Latest:
Vaccines Are Entering a Period of Simultaneous Expansion and ContractionWhile vaccine research and approvals continue to break new ground, use and faith in them are faltering.
Latest:
White Paper: DIR Fees Simply ExplainedThis paper examines the use and implications of direct and indirect remuneration (DIR) fees and potential strategies to overcome the challenges that accompany DIR fees.
Latest:
Patient-Centered Approach Helps Ensure Biosimilar Adoption SuccessEducating patients, providers improves acceptance, trust as number of approvals, indications grows
Latest:
Do You Know How to Speed Network?More than 80 pharmacy professionals helped 100 Rutgers pharmacy students practice their networking skills at a recent event that used a speed dating format.
Latest:
Roundup: Formulary Considerations for VTEVenous thromboembolism is a major cause of morbidity and mortality in the health system, and all patients should be assessed to determine their level of risk. The latest prophylactic treatment guidelines are presented here.
